| Symbol | DERM |
|---|---|
| Name | JOURNEY MEDICAL CORP |
| Sector | HEALTH CARE |
| Region | North America |
| Industry | Pharmaceutical Preparations |
| Address | 9237 E VIA DE VENTURA BLVD., SUITE 105, SCOTTSDALE, AZ 85258 |
| Telephone | 480-434-6670 |
| Fax | — |
| — | |
| Website | https://www.journeymedicalcorp.com |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0001867066 |
| Description | Journey Medical Corp is focused on identifying, acquiring, developing and strategically commercializing innovative, differentiated dermatology products through its efficient sales and marketing model. Additional info from NASDAQ: |
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Journey Medical Corporation - DERM
Read moreJourney Medical Corporation to Announce First Quarter 2026 Financial Results on May 13, 2026
Read moreJourney Medical Corporation to Announce First Quarter 2026 Financial Results on May 13, 2026
Read moreINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Journey Medical Corporation - DERM
Read moreNew Form DEFA14A - Journey Medical Corp <b>Filed:</b> 2026-04-30 <b>AccNo:</b> 0001104659-26-052915 <b>Size:</b> 317 KB
Read moreNew Form DEF 14A - Journey Medical Corp <b>Filed:</b> 2026-04-30 <b>AccNo:</b> 0001104659-26-052883 <b>Size:</b> 2 MB
Read moreNew Form SCHEDULE 13G - Journey Medical Corp <b>Filed:</b> 2026-04-30 <b>AccNo:</b> 0002100119-26-000697 <b>Size:</b> 7 KB
Read moreBenesch Joseph 🟢 acquired 70.8K shares (1 derivative) of Journey Medical Corp (DERM) at $5.04 Transaction Date: Apr 22, 2026 | Filing ID: 048733
Read more(10% Negative) JOURNEY MEDICAL CORP (DERM) Announces Delay in products Trials for adults Due to Pandemic-Related Challenges, Safety Review, Efficacy Assessment
Read moreJourney Medical Corporation Secures Contract with Third Major GPO forEmrosi™
Read more